Fitzpatrick Institute for Photonics Fitzpatrick Institute for Photonics
Pratt School of Engineering
Duke University

 HOME > pratt > FIP    Search Help Login pdf version printable version 

Publications [#191215] of Aimee K Zaas

Papers Published

  1. AK Zaas, X Song, P Tucker, TM Perl, Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 35 no. 10 (November, 2002), pp. 1139-46, ISSN 1537-6591 [doi]
    (last updated on 2011/05/02)

    Abstract:
    Vancomycin-resistant Enterococcus faecium (VRE) is a common nosocomial isolate, especially among patients with cancer. VRE infections have substantial attributable mortality among patients with cancer. The purpose of this study was to identify risk factors for developing bloodstream infection with VRE in patients with cancer who are colonized with VRE. VRE colonization was prospectively identified in 197 patients with cancer during 4-year period, of whom 179 (91%) had complete records for evaluation. Of these 179 patients, 24 (13.4%) developed hospital-acquired VRE bloodstream infections. Risk factors for VRE bloodstream infection included vancomycin use (relative risk [RR], 1.98; 95% confidence interval [CI], 1.25-3.14), diabetes mellitus (RR, 3.91; 95% CI, 1.20-12.77), gastrointestinal procedures (RR, 4.56; 95% CI, 1.05-19.7), and acute renal failure (RR, 3.10; 95% CI, 1.07-8.93). Strategies for preventing VRE bloodstream infection in VRE-colonized patients with cancer should include limiting vancomycin use and, perhaps, gastrointestinal procedures.

    Keywords:
    Bacteremia • Enterococcus faecium* • Female • Gram-Positive Bacterial Infections • Humans • Male • Middle Aged • Neoplasms • Risk Factors • Vancomycin Resistance • complications* • epidemiology • etiology • microbiology • microbiology* • physiology*


Duke University * Pratt * Reload * Login